Psychotomimetic N-Methyl-N-isopropyltryptamines. Effects of Variation of Aromatic Oxygen Substituents

Journal of Medicinal Chemistry

Volumn 28, Issue 7, 1985, Pages 892-896

  Repke, David B ^a   Grotjahn, Douglas B ^a   Shulgin, Alexander T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PSYCHEDELIC AGENT;

4 HYDROXY N ISOPROPYL N METHYLTRYPTAMINE; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG ANALYSIS; DRUG COMPARISON; DRUG IDENTIFICATION; DRUG RESPONSE; DRUG SCREENING; DRUG SYNTHESIS; HALLUCINATION; HUMAN; HUMAN EXPERIMENT; N ISOPROPYL N METHYLTRYPTAMINE; N ISOPROPYL N METHYLTRYPTAMINE DERIVATIVE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADULT; CHEMISTRY; COMPARATIVE STUDY; HALLUCINATIONS; HALLUCINOGENS; HUMAN; KINETICS; MIDDLE AGE; OXYGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTAMINES;

EID: 0021846044     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00145a007     Document Type: Article

References (38)

1. Repke, D. B.; Ferguson, W. J.; Bates, D. K. J. Heterocycl. Chem. 1977, 14, 71.
2. Repke, D. B.; Ferguson, W. J.; Bates, D. K. J. Heterocycl. Chem. 1981, 18, 175.
3. Repke, D. B.; Ferguson, W. J. J. Heterocycl. Chem. 1982, 19, 845.
4. Shulgin, A. T.; Carter, M. F. Commun. Psychopharmacol. 1980, 4, 363.
5. Shulgin, A. T.; Nichols, D. E. In “The Psychopharmacology of Hallucinogens”; Willette, R. E., Stillman, R. E., Eds.; Pergamon Press: New York, 1978; pp 74–83.
6. Grotjahn, D. B. J. Heterocycl. Chem. 1983, 20, 1031.
7. Shulgin, A. T.; Sargent, T.; Naranjo, C. Nature (London) 1969, 221, 537.
8. Shulgin, A. T. In “Psychotomimetic Drugs”; Efron, D. H., Ed.; Raven Press: New York, 1970; pp 21–38.
9. Shulgin, A. T. In “Psychopharmacological Agents”; Gordon, M., Ed.; Academic Press: New York, 1976; Vol. 4, pp 59–146.
10. Shulgin, A. T. In “Handbook of Psychopharmacology”; Iverson, L. L., Iverson, S. D., Snyder, S. H., Eds.; Plenum Press: New York, 1978; Vol. 2, pp 246–333.
11. Shulgin, A. T. In “Handbook of Experimental Pharmacology”; Hoffmeister, F., Stille, G., Eds.; Springer-Verlag: Berlin, 1982; Vol. 55 III, p 9.
12. Faillace, L. A.; Vourlekis, A.; Szara, S. J. Nerv. Ment. Dis. 1967, 145, 306. (13) Szara, S.; Hearst, E. Ann. N.Y. Acad. Sci. 1962, 96, 134.
13. Bradley, R. J.; Johnston, V. S. In “Origins and Mechanisms of Hallucinations”; Keup, W., Ed., Plenum Press: New York, 1970; pp 333–344.
14. Hollister, L. E. Arch. Int. Pharmacodyn. Ther. 1961, 130, 42.
15. Brimblecombe, R. W.; Pinder, R. M. “Hallucinogenic Agents”; Bristol: Wright-Scientechnica, Dorchester, 1975; pp 106–107.
16. Gessner, P. K. In “Psychotomimetic Drugs”; Efron, D. H., Ed.; Raven Press: New York, 1970; pp 105–122.
17. Kalir, A.; Balderman, D.; Edery, H.; G. Porath, Isr. J. Chem. 1967, 5, 129.
18. Kline, T. B.; Benington, F.; Morin, R. D.; Beaton, J. M. J. Med. Chem. 1982, 25, 908.
19. Elkes, J. “Monoamines et Systeme Nerveux Centrale”; Georg Thieme Verlag: Geneva, 1962; pp 153–166.
20. Rosenberg, D. E.; Isbell, H.; Miner, E. J. Psychopharmacologia 1963, 4, 39.
21. Taborsky, R. G.; Delvigs, P.; Page, I. H. Science 1966, 153, 1018.
22. Brown, V. H.; Skinner, W. A.; DeGraw, J. I. J. Heterocycl. Chem. 1969, 6, 539.
23. Carlsson, A.; Corrodi, H.; Magnusson, T. Helv. Chim. Acta 1963, 46, 1231.
24. Nir, I.; Weller, C. P.; Sulman, F. G. Psychopharmacologia 1974, 39, 323. (26) Gessner, P. K.; Godse, D. D.; Krull, A. H.; McMullan, J. M. Life Sci. 1968, 7, 267.
25. Repke, D. B., unpublished studies.
26. Blaikie, K. G.; Perkin, W. H. J. Chem. Soc. 1924, 125, 328.
27. Blaikie, K. G.; Perkin, W. H. J. Chem. Soc. 1924, 125, 296. (30) Kermack, W. O.; Perkin, W. H.; Robinson, R. J. Chem. Soc. 1921, 119, 1602.
28. Leimgruber, W.; Batcho, A. D. “Abstracts of Papers”; Third International Congress of Heterocyclic Chemistry, Tohoku University, Sendai, Japan, 1971; U.S. Patent 3 976 639, 1976.
29. For a recent review of the Leimgruber-Batcho synthesis, see: Clark, R. D.; Repke, D. B. Heterocycles 1984, 22, 195.
30. Huebner, C. F.; Troxell, H. A.; Schroeder, D. C. J. Am. Chem. Soc. 1953, 75, 5887.
31. Flaugh, M. E.; Crowell, T. A.; Clemens, J. A.; Sawyer, B. D. J. Med. Chem. 1979, 22, 63. (35) Randrup, A.; Munkvad, I. Psychopharmacologia 1967, 11, 300.
32. Weiss, B.; Laties, V. G. Pharmacol. Rev. 1962, 14, 1.
33. Uyeno, E. T. Int. J. Neuropharmacol. 1969, 8, 245.
34. Uyeno, E. T. Psychopharmacologia 1971, 19, 381.
35. Repke, D. B.; Ferguson, W. J.; Bates, D. K. Tetrahedron Lett. 1979, 4183.
36. Kantor, R. E.; Dudlettes, S. D.; Shulgin, A. T.Biol. Psychiatry 1980, 15, 349
37. Hofmann, A. Bull. Nar. 1971, 23, 3.
38. Alles, G. A. In “Neuropharmacology”; Abramson, H. A., Ed.; Josiah Macy, Jr. Foundation: New York, 1957; pp 181-268.